Amgen: Accelerating The Business And Dividend Growth

ipopba Amgen Inc. (NASDAQ:AMGN) has an impressive total return and dividend growth track record with a solid financial foundation, but faces operational challenges under the burden of significant investment. While this could undermine its dividend growth performance long term, I believe the company's balance sheet will continue to allow the company to shape itself as a leading U.S. equity and commitment to long-term shareholder value. Company & Performance AMGN operates as a leading global biopharmaceut ...